
In the wake of economic growth, healthcare reforms, and large-scale industry investment, Turkish pharmaceutical companies are charting their own destiny.
Guillaume Doane is a country editor for Executive Country Reviews, a press agency headquartered in Paris and Istanbul.

Published: October 2nd 2008 | Updated: